Skip to content

Treatment of exacerbations of Chronic Obstructive Pulmonary Disease - a co-operation between primary health care and hospital care: a prospective, randomised trial

Treatment of exacerbations of Chronic Obstructive Pulmonary Disease - a co-operation between primary health care and hospital care: a prospective, randomised trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN43868741
Enrollment
128
Registered
2005-09-12
Start date
2004-11-01
Completion date
Unknown
Last updated
2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease (COPD) Respiratory Pulmonary diseases

Interventions

Control arm: patients with exacerbation COPD receive 'care as usual'. Intervention arm: patients with exacerbations are treated by their General Practitioner (GP) following the study p

Sponsors

University Maastricht (The Netherlands)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patient meets the clinical criteria of Chronic Obstructive Pulmonary Disease (COPD): a. Chronic bronchitis: chronic cough and sputum production on most days during at least three months of the year, during at least two consecutive years and/or b. COPD defined as an expiratory flow obstruction determined by spirometry, where the disorder does not vary seriously during several months of observation 2. Diagnosis of COPD in medical dossier 3. Indications for exacerbation a. Increased dyspnoe, +/- accompanied by increased volume and/or purulence of sputum and/or cough b. Increased dyspnoe developed in a short period (less than four weeks) c. Adaptation in medication is necessary

Exclusion criteria

Exclusion criteria: 1. Inadequate cognitive functioning 2. Inadequate of mastering the Dutch language 3. Terminal patient 4. Other infection at the same time that needs antibiotic treatment 5. Serious underlying diseases: Acquired Immune Deficiency Syndrome (AIDS), neutropenia less than 1.0 x 10^9/l 6. Age less than 40 or more than 80 years

Design outcomes

Primary

MeasureTime frame
Improvement in patients' health (faster recovery).

Secondary

MeasureTime frame
The health care process (use of antibiotics and health care services).

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026